🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the pharmacokinetics of AZD6140 and ...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT01588626
Treatments Being Tested
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
The purpose of this study is to compare the effects of ticagrelor and clopi...
Status
Completed
Location
Research Site
Start Date
2012-12-04
Trial ID
NCT01732822
Treatments Being Tested
Oral antiplatelet therapy is a key treatment of the STEMI (ST elevation myo...
Status
Terminated
Location
CHU de Bordeaux - Hôpital du Haut Lévèque
Start Date
2014-12-08
Trial ID
NCT02251249
Treatments Being Tested
The study aims to show inferiority of rivaroxaban plus ticagrelor when comp...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04023630
Treatments Being Tested
The purpose of this study is to compare the effect of ticagrelor versus pla...
Status
Completed
Location
Research Site
Start Date
2014-02-10
Trial ID
NCT01991795
Treatments Being Tested
The purpose of this study is to see how Ticagrelor, a new oral reversible a...
Status
Completed
Location
Research Site
Start Date
2007-10
Trial ID
NCT00528411
Treatments Being Tested
Patients with COPD (chronic bronchitis and/or emphysema) are known to be at...
Status
Completed
Location
Newcastle upon Tyne Hospitals NHS Foundation Trust
Start Date
2015-09
Trial ID
NCT03487406
Treatments Being Tested
The purpose of this study is to see how Ticagrelor, a new oral reversible a...
Status
Completed
Location
Research Site
Start Date
2008-05
Trial ID
NCT00642811
Treatments Being Tested
To evaluate the relative bioavailability of ticagrelor for the different fo...
Status
Completed
Location
Research Site
Start Date
2017-05-12
Trial ID
NCT03126695